Risk of HLA Homozygous Cord Blood Transplantation: Implications for Induced Pluripotent Stem Cell Banking and Transplantation

Clinical application of induced pluripotent stem cells (iPS) in autologous settings has just begun. To overcome the high time and cost barriers in the individual production of autologous iPS, the use of allogeneic iPS with a homozygous human leukocyte antigen (HLA) haplotype (HLA‐homo HP) has been p...

Descripción completa

Detalles Bibliográficos
Autores principales: Morishima, Yasuo, Azuma, Fumihiro, Kashiwase, Koichi, Matsumoto, Kayoko, Orihara, Takeshi, Yabe, Hiromasa, Kato, Shunichi, Kato, Koji, Kai, Shunro, Mori, Tetsuo, Nakajima, Kazunori, Morishima, Satoko, Satake, Masahiro, Takanashi, Minoko, Yabe, Toshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Translational Research Articles and Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788882/
https://www.ncbi.nlm.nih.gov/pubmed/29274116
http://dx.doi.org/10.1002/sctm.17-0169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788882/
https://www.ncbi.nlm.nih.gov/pubmed/29274116
http://dx.doi.org/10.1002/sctm.17-0169

Ejemplares similares